Status: Not yet recruiting
Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux Disease
This study aims to evaluate the efficacy and safety of JP-1366 in Patients with NERD
Participants needed: 321
Trial details
Phase: Phase 3Age: 19-75Biological sex: AllType: InterventionalSponsor: Onconic Therapeutics Inc.Updated: Sep 8, 2025
Eligibility criteria
Subjects who have experienced both heartburn and acid regurgitation [+2]
Subjects who have significant gastrointestinal diseases or procedures affecting... [+6]